We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Chembio Diagnostics, Inc. has submitted a CLIA waiver application to the United States Food & Drug Administration for the Company's SURE CHECK(R) HIV 1/2 rapid diagnostic test.
The Board of Directors of Advanced Medical Institute Inc. announced that the Company's indirect wholly owned subsidiary, Intelligent Medical Technologies Pty Limited (IMT) has terminated its license agreement with Sheiman Ultrasonic Research Foundation Pty Limited (SURF), related to the use of certain ultrasonic nebulizer technologies.
Thursday, Boston Scientific Corp., medical device company, revealed second quarter financial results, reporting a net loss primarily from charges related to the acquisition of Guidant Corp.
Many FDA scientists are subject to "pervasive and dangerous political influence" that has affected medical device approvals, according to a new Union of Concerned Scientists (UCS) survey report issued July 20.